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tive MRSA isolates and that genotypes 
for some CA-MRSA strains are shared 
by a few of the MSSA strains (1).
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Clostridium difﬁ  cile 
in Ground Meat, 
France
To the Editor:  Clostridium dif-
ﬁ  cile is a toxigenic enteropathogen re-
sponsible for 15%–20% of antimicro-
bial drug–associated diarrhea and for 
almost all cases of pseudomembranous 
colitis. Two protein toxins (TcdA and 
TcdB) play a major role in the patho-
genesis of infections. C. difﬁ  cile is also 
recognized as a cause of disease in 
several animal species, which could be 
potential reservoirs (1). In the past few 
years, the presence of C. difﬁ  cile in 
raw diets for dogs and cats and in retail 
meat sold for human consumption has 
been reported in the United States and 
Canada at rates from 6% to 42% (2–5). 
To determine C. difﬁ  cile contamina-
tion of meat in France, we evaluated 
105 packages of ground beef (vacuum 
packed or not), 59 pork sausages, and 
12 packages of feline raw diet meat 
purchased from 20 urban and suburban 
Paris retail stores and supermarkets 
during September 2007–July 2008. 
C. difﬁ  cile spores or vegetative 
forms in samples were found as de-
scribed by Rodriguez-Palacios et al. 
(4). Brieﬂ  y, 5 g of each sample was 
cultured in 100 mL of prereduced 
brain–heart infusion (BHI) broth sup-
plemented with cefoxitin (10 μg/mL), 
cycloserine (250 μg/mL), and tauro-
cholate (0.1%). After the samples were 
incubated under anaerobic conditions 
at 37°C for 72 h, subculturing with 
and without alcohol shock for spore 
selection was performed. The BHI 
broth culture was treated with 2 mL of 
absolute ethanol (1:1 vol/vol) for 30 
min and centrifuged at 3,800 × g for 
10 min, and the pellet was resuspend-
ed in 200 μL of prereduced BHI broth. 
Serial dilutions of the BHI broth and 
the pellet were injected onto Colum-
bia cysteine agar supplemented with 
cefoxitin-cycloserine, taurocholate, 
and 5% horse blood and incubated an-
aerobically for 48 h at 37°C.
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C. difﬁ  cile colonies were identi-
ﬁ  ed classically, and susceptibilities to 
moxiﬂ   oxacin, teicoplanin, vancomy-
cin, metronidazole, linezolid, levo-
ﬂ  oxacin, telithromycin, erythromycin, 
and lincomycin were determined by 
the agar disk-diffusion methods de-
scribed by the French Society for Mi-
crobiology (www.sfm.asso.fr). PCR 
ampliﬁ   cations of a species-speciﬁ  c 
internal fragment of the triose phos-
phate isomerase (tpi) gene, an internal 
fragment of the toxin B (tcdB) gene, 
and the 3′ region of the toxin A (tcdA) 
gene were performed as described by 
Lemee et al. (6). Strains were charac-
terized by toxinotyping according to 
Rupnik et al. (7) and PCR-ribotyping 
as described by Bidet et al. (8).
The detection threshold of the 
enrichment method was established 
by spiking known uninfected samples 
(ground beef, pork sausage, and fe-
line raw diets) with vegetative cells 
and spores of C. difﬁ  cile (VPI 10463 
strain). For ground beef samples, the 
detection thresholds for vegetative 
forms and spores were 2 CFU/5 g and 
4.5 CFU/5 g of meat, respectively. For 
pork sausages, the detection thresh-
olds were 14 CFU/5 g and 38 CFU/5 
g of sample after 72 h, for vegetative 
forms and spores, respectively. For fe-
line raw diets, the detection threshold 
of spores was 2 CFU/5 g of sample. In 
addition, toxin B was detected in the 
culture supernatants by the cytotoxic-
ity assay onto MRC-5 cells. Toxin de-
tection showed 100% agreement with 
the culture method.
C. difﬁ  cile was not detected in 
pork sausages or in commercial feline 
raw diets. C. difﬁ  cile was isolated from 
2 (1.9%) of 105 ground beef, but only 
from those packages that were vacuum 
packed. The anaerobic atmosphere of 
vacuum packaging could facilitate the 
survival of C. difﬁ  cile and the germi-
nation of spores. These 2 isolates were 
fully susceptible to moxiﬂ  oxacin, tei-
coplanin, vancomycin, metronidazole, 
and linezolid but resistant to levo-
ﬂ  oxacin, telithromycin, erythromycin, 
and lincomycin. They harbored genes 
encoding for Tpi protein and for TcdA 
and TcdB. The 2 strains belonged to 
the toxinotype 0 and PCR-ribotype 
012. Toxinotype 0 was already iden-
tiﬁ  ed in meat samples in Canada (4). 
PCR-ribotype 012 belongs to the 10 
ribotypes most frequently isolated 
from humans (9).
The prevalence of C. difﬁ  cile in 
ground meat in France is low com-
pared with the prevalence reported 
by other countries. In Canada, Rodri-
guez-Palacios et al. (4) studied 60 beef 
samples and found the prevalence of 
C. difﬁ  cile to be 20%. These same 
authors, by using a broader sampling 
scheme (214 meat samples), isolated 
C. difﬁ  cile from 6% of the samples 
(5). Also in Canada, Weese et al. (10) 
reported that 12% of ground beef and 
ground pork samples were contami-
nated. In the United States, C. dif-
ﬁ  cile was isolated from 42% of meat 
samples (beef, pork, and turkey prod-
ucts) (3).
For a better understanding of the 
sources of C. difﬁ  cile in France, it 
would be interesting to determine its 
prevalence  in different animal fecal 
samples and the toxinotypes associ-
ated with animals. The low prevalence 
in retail meat in France could result 
from hazard analysis critical control 
point principles and microbiologic 
quality controls implemented through-
out the food production chain, which 
help reduce the spread of C. difﬁ  cile 
and minimize the risk for infection for 
the consumer.
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WUPyV in Children 
with Acute 
Respiratory Tract 
Infections, China
To the Editor: WU polyomavirus 
(WUPyV) is a human polyomavirus 
ﬁ   rst detected in respiratory samples 
in 2007 (1). It has since been detect-
ed worldwide (2–7), including the 
People’s Republic of China (8), but 
whether it is a causative respiratory 
pathogen remains speculative. To in-
vestigate the potential role of WUPyV 
in respiratory diseases and its preva-
lence in Tianjin, China, we examined 
samples obtained from children with 
upper respiratory tract infections (UR-
TIs) and lower respiratory tract infec-
tions (LRTIs) by using PCR for the 
VP2 and LTAg genes, as described 
previously (1). As a control, we also 
tested samples from patients who did 
not have respiratory diseases. 
Case-patients were 174 inpatients, 
hospitalized for LRTIs March–April 
2008 and September 2008–February 
2009, and 68 outpatients treated for 
URTIs November–December 2009 at 
Tianjin Children’s Hospital. Controls 
were 43 outpatients with illnesses 
other than respiratory diseases treated 
at Tianjin Xianshuigu Hospital. Most 
patients with LRTIs had pneumonia 
or bronchitis. Case-patient age ranged 
from 3 hours to 12 years; for 1 patient, 
age was unknown (Table). Nasopha-
ryngeal aspirate samples were col-
lected from hospitalized children, and 
throat swabs were obtained from out-
patients with URTIs and from control 
children.
Of the 174 nasopharyngeal aspi-
rate specimens tested, 28 (16%) had 
WUPyV VP2 gene–positive frag-
ments; 24 had LTAg gene–positive 
fragments. Four VP2-positive but 
LTAg-negative fragments were se-
quenced; nucleotide sequences were 
identical to WUPyV strains in Gen-
Bank. Mean age of WUPyV-infected 
patients was 11.7 months (range 12 
days–39 months); 10 patients (36%) 
were <6 months of age, 10 (36%) 
were 6 months–1 year, 7 (25%) were 
1–2 years, and 1 (4%) was 2–5 years 
of age. The age distribution was simi-
lar to that of the original cohort. We 
found WUPyV-positive samples in 
most months, except for March 2008. 
Highest proportion of WUPyV-pos-
itive samples occurred in December 
2008 (27%), followed by April 2008 
(25%), November 2008 (22%), and 
February 2009 (19%).
We detected WUPyV VP2 frag-
ment–positive specimens by multi-
PCR using the Seeplex RV Detection 
kit-1 (Seegene, Seoul, South Korea) 
for other respiratory viruses, includ-
ing adenovirus, parainﬂ  uenza viruses 
1, 2, 3 (PIV1, 2, 3), inﬂ  uenza viruses 
A and B, rhinovirus (rhinovirus V), 
human metapneumovirus, respiratory 
syncytial virus A and B (RSV A, B), 
and coronaviruses OC43/HKU1 and 
229E/NL63, according to the manu-
facturers’ instructions. First strands 
of cDNA were produced by using the 
RevertAid First Strand cDNA Synthe-
sis Kit (Fermentas, Glen Burnie, MD, 
USA). Human bocavirus (HBoV) was 
tested as described previously (9).
Twenty (71%) case-patients were 
co-infected with other respiratory vi-
ruses, most commonly RSV B (9/28, 
32%), followed by HBoV (6/28, 21%), 
rhinovirus V and PIV3 (4 each of 28, 
14%), human metapneumovirus (3/28, 
11%), adenovirus and inﬂ  uenza A (2 
each of 28, 7%), and 229E (1/28, 4%). 
Of 20 patients with co-infections, 14 
(50%) were infected with 2 viruses; 
2 (7%) with 3 viruses (WU, RSV B, 
PIV3; and WU, inﬂ  uenza  virus,  A, 
HBoV); 3 (11%), with 4 viruses (WU, 
RSV B, PIV3, inﬂ  uenza A; WU, RSV 
B, PIV3, HBoV; and WU, RSV B, rhi-
novirus V, HBoV); and 1 (4%), with 
5 viruses (WU, RSV B, PIV3, BoV, 
rhinovirus V).
Three (4%) of 68 throat swabs 
from outpatients with URTIs were 
WUPyV positive, substantially low-
er than from inpatients with LRTIs. 
Among 3 WUPyV-positive case-
patients, 2 were 2 years of age and 1 
was 3. No WUPyV was detected in 43 
control samples.
The prevalence of WUPyV in 
hospitalized children with acute respi-
ratory tract infections in Tianjin was 
16.1%, higher than 7.1% found in a 
study in the United States (3); 4.9% 
in Germany (4); 4.5% in Australia 
(5); 6.29% in Thailand (6); and 2.2% 
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Table. Age distribution of children infected with WU polyomavirus, Tianjin, People’s 
Republic of China, 2008–2009* 
Age
Inpatients with 
LRTIs
Outpatients with 
URTIs 
Children without 
respiratory diseases 
Mean ± SD, y  10.2 ± 16.1  5.96 ± 3.69  7.56 ± 4.25 
Median age, y 0.4 5.0 7.0
Age group 
  <6 mo  95 (54.6)  1 (1.5)  0
  6 mo–<1 y  52 (29.9)  1 (1.5)  0
  1–<2 y  15 (8.6)  3 (4.4)  2 (4.6) 
  2–5 y  9 (5.2)  25 (36.8)  11 (25.6) 
  >5 y  2 (1.1)  38 (55.9)  30 (69.8) 
 Unknown  1  (0.6)  0 0
Total 174 (100.0)  68 (100.0)  43 (100.0) 
* LRTIs, lower respiratory tract infections; URTIs, upper respiratory tract infections. Values are no. 
(%) unless otherwise indicated.  